Latest news

Genialis advances biomarker discovery to reduce risk in cancer drug development targeting DNA damage response pathways

Genialis and Debiopharm Set Up Biomarker Discovery Collaboration

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response